GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Equity-to-Asset

Cangene (FRA:YGE) Equity-to-Asset : 0.67 (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cangene's Total Stockholders Equity for the quarter that ended in Oct. 2013 was €140.58 Mil. Cangene's Total Assets for the quarter that ended in Oct. 2013 was €208.85 Mil. Therefore, Cangene's Equity to Asset Ratio for the quarter that ended in Oct. 2013 was 0.67.

The historical rank and industry rank for Cangene's Equity-to-Asset or its related term are showing as below:

FRA:YGE's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

Cangene Equity-to-Asset Historical Data

The historical data trend for Cangene's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Equity-to-Asset Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.82 0.84 0.84 0.69

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.82 0.68 0.69 0.67

Competitive Comparison of Cangene's Equity-to-Asset

For the Biotechnology subindustry, Cangene's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cangene's Equity-to-Asset falls into.



Cangene Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cangene's Equity to Asset Ratio for the fiscal year that ended in Jul. 2013 is calculated as

Equity to Asset (A: Jul. 2013 )=Total Stockholders Equity/Total Assets
=150.438/218.9
=0.69

Cangene's Equity to Asset Ratio for the quarter that ended in Oct. 2013 is calculated as

Equity to Asset (Q: Oct. 2013 )=Total Stockholders Equity/Total Assets
=140.578/208.847
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene  (FRA:YGE) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cangene Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cangene's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines